JOHNSON JOHN
Insider CIK 1410781 · DNDN Pres & Chief Executive Officer, Director · PTLA Director · TZYM Director · AVEO Director · SCMP Director · HSGX Director · CEMP Interim CEO, Director · VSTM Director · SBBP Executive Chairman, Director · APLT Executive Chairman, Director · XERS Director · SVNT Chief Executive Officer, Director · AXGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AXGN Axogen, Inc. | A Award deriv | 2026-06-24 | 2026-06-26 | 4,392 | — | $0 | 4,392 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2026-06-19 | 2026-06-23 | 14,150 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2026-06-19 | 2026-06-23 | 14,150 | — | $0 | 14,150 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2026-06-04 | 2026-06-05 | 32,996 | $6.15 | $202.9K | 32,996 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2026-06-04 | 2026-06-05 | 15,000 | $6.09 | $91.3K | 683,083 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2026-06-04 | 2026-06-05 | 24,193 | — | $0 | 707,276 | SEC↗ |
| VSTM Verastem, Inc. | A Award | 2026-05-21 | 2026-05-26 | 36,000 | — | $0 | 52,666 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2026-05-07 | 2026-05-08 | 11,050 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2026-05-07 | 2026-05-08 | 11,050 | $43.26 | $478.0K | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2026-05-07 | 2026-05-08 | 11,050 | $7.04 | $77.8K | 11,050 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2025-12-19 | 2025-12-19 | 135,400 | $7.22 | $977.6K | 698,083 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2025-12-09 | 2025-12-10 | 8,545 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2025-12-09 | 2025-12-10 | 13,141 | $29.98 | $394.0K | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2025-12-09 | 2025-12-10 | 8,545 | $6.30 | $53.8K | 21,686 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2025-12-09 | 2025-12-10 | 8,545 | $29.98 | $256.2K | 13,141 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2025-12-08 | 2025-12-10 | 11,891 | — | $0 | 8,545 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2025-12-08 | 2025-12-10 | 11,802 | $31.26 | $368.9K | 13,141 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2025-12-08 | 2025-12-10 | 11,891 | $6.30 | $74.9K | 25,032 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2025-12-08 | 2025-12-10 | 11,891 | $31.22 | $371.2K | 13,141 | SEC↗ |
| XERS Xeris Biopharma Holdings, | S Sale | 2025-08-13 | 2025-08-15 | 107,500 | $7.32 | $786.9K | 833,483 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2025-06-19 | 2025-06-20 | 14,150 | — | $0 | 14,150 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2025-06-09 | 2025-06-11 | 4,073 | $10.61 | $43.2K | 24,943 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2025-06-04 | 2025-06-04 | 50,000 | — | $0 | 940,983 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2025-05-22 | 2025-05-27 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VSTM Verastem, Inc. | A Award | 2025-05-22 | 2025-05-27 | 8,333 | — | $0 | 16,666 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award deriv | 2024-12-19 | 2024-12-20 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| APLT Applied Therapeutics, Inc. | A Award | 2024-12-19 | 2024-12-20 | 500,000 | — | $0 | 500,000 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2024-09-01 | 2024-09-04 | 11,904 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2024-09-01 | 2024-09-04 | 11,904 | — | $0 | 29,016 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VSTM Verastem, Inc. | A Award | 2024-06-18 | 2024-06-20 | 8,333 | — | $0 | 8,333 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 18,248 | — | $0 | 18,248 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2024-06-06 | 2024-06-10 | 10,653 | — | $0 | 17,112 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2024-06-05 | 2024-06-05 | 50,000 | — | $0 | 890,983 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise deriv | 2024-03-18 | 2024-03-18 | 215,600 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | M Exercise | 2024-03-18 | 2024-03-18 | 215,600 | $1.99 | $429.0K | 751,412 | SEC↗ |
| XERS Xeris Biopharma Holdings, | J Other | 2024-03-15 | 2024-04-01 | 89,571 | — | $0 | 840,983 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,300 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,083 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2024-03-11 | 2024-03-13 | 8,549 | — | $0 | 8,549 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,083 | — | $0 | 0 | SEC↗ |
| VSTM Verastem, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-13 | 2,083 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2023-09-01 | 2023-09-07 | 20,436 | — | $0 | 20,436 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2023-09-01 | 2023-09-07 | 11,904 | — | $0 | 11,904 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2023-06-07 | 2023-06-07 | 42,500 | — | $0 | 535,812 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2023-06-01 | 2023-06-05 | 6,459 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2023-06-01 | 2023-06-05 | 6,459 | — | $0 | 6,459 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2023-05-15 | 2023-05-16 | 62,500 | — | $0 | 62,500 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 62,500 | — | $0 | 62,500 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2022-06-08 | 2022-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2022-06-08 | 2022-06-09 | 15,000 | — | $0 | 493,312 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2022-06-01 | 2022-06-03 | 11,811 | — | $0 | 11,811 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2022-06-01 | 2022-06-03 | 6,459 | — | $0 | 6,459 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2022-05-12 | 2022-12-20 | 62,500 | — | $0 | 62,500 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 215,600 | — | $0 | 215,600 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 31,360 | — | $0 | 31,360 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 68,600 | — | $0 | 68,600 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 10,367 | — | $0 | 10,367 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 31,360 | — | $0 | 31,360 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 31,360 | — | $0 | 31,360 | SEC↗ |
| SBBP Strongbridge Biopharma plc | D To issuer deriv | 2021-10-05 | 2021-10-06 | 495,724 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-08 | 10,367 | — | $0 | 10,367 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-08 | 31,360 | — | $0 | 31,360 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-08 | 31,360 | — | $0 | 31,360 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-08 | 31,360 | — | $0 | 31,360 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-08 | 215,600 | — | $0 | 215,600 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-08 | 19,650 | $2.37 | $46.6K | 19,650 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-08 | 68,600 | — | $0 | 68,600 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 478,312 | — | $0 | 478,312 | SEC↗ |
| SBBP Strongbridge Biopharma plc | D To issuer | 2021-10-05 | 2021-10-06 | 610,092 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-08 | 478,312 | — | $0 | 478,312 | SEC↗ |
| SBBP Strongbridge Biopharma plc | F Tax w/h | 2021-10-01 | 2021-10-05 | 334,868 | $2.06 | $689.8K | 610,092 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2021-07-19 | 2021-07-21 | 27,638 | — | $0 | 27,638 | SEC↗ |
| SBBP Strongbridge Biopharma plc | F Tax w/h | 2021-07-02 | 2021-07-07 | 50,867 | $3.08 | $156.7K | 944,960 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2021-06-28 | 2021-06-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SBBP Strongbridge Biopharma plc | F Tax w/h | 2021-04-08 | 2021-04-09 | 17,325 | $2.68 | $46.4K | 995,827 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award | 2021-01-07 | 2021-01-08 | 491,000 | — | $0 | 1,013,152 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 54,991 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 11,377 | $0.06 | $683 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2020-07-02 | 2020-07-02 | 13,194 | $18.00 | $237.5K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2020-07-02 | 2020-07-02 | 7,281 | $18.00 | $131.1K | 0 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award | 2020-07-02 | 2020-07-07 | 315,000 | — | $0 | 522,152 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2020-06-16 | 2020-06-18 | 27,602 | — | $0 | 27,602 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2020-06-12 | 2020-06-15 | 11,377 | — | $0 | 11,377 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2020-06-12 | 2020-06-15 | 7,281 | — | $0 | 20,475 | SEC↗ |
| SBBP Strongbridge Biopharma plc | F Tax w/h | 2020-05-15 | 2020-05-18 | 15,348 | $2.86 | $43.9K | 207,152 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2020-04-29 | 2020-04-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award deriv | 2020-04-08 | 2020-04-10 | 87,500 | — | $0 | 87,500 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award | 2020-04-08 | 2020-04-10 | 182,500 | — | $0 | 222,500 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award deriv | 2019-11-14 | 2019-11-18 | 275,000 | — | $0 | 275,000 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | S Sale | 2019-06-27 | 2019-07-02 | 13,000 | $5.57 | $72.4K | 37,400 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2019-06-13 | 2019-06-17 | 6,991 | — | $0 | 6,991 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2019-06-13 | 2019-06-17 | 4,194 | — | $0 | 13,194 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | M Exercise deriv | 2019-05-22 | 2019-06-26 | 50,000 | — | $0 | 350,000 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | M Exercise | 2019-05-22 | 2019-06-26 | 50,000 | — | $0 | 50,400 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award | 2019-05-15 | 2019-05-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | A Award deriv | 2019-02-22 | 2019-02-26 | 400,000 | — | $0 | 400,000 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | A Award deriv | 2018-10-26 | 2018-10-29 | 150,000 | — | $0 | 150,000 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | A Award deriv | 2018-10-26 | 2018-10-29 | 50,000 | — | $0 | 50,000 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2018-06-15 | 2018-06-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | A Award deriv | 2018-06-12 | 2018-06-14 | 9,100 | — | $0 | 9,100 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | A Award deriv | 2018-06-12 | 2018-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2018-06-08 | 2018-06-08 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2018-06-08 | 2018-06-08 | 3,000 | — | $0 | 9,000 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award deriv | 2018-05-15 | 2018-05-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 10,000 | $7.70 | $77.0K | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 30,000 | $4.08 | $122.4K | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 20,000 | $1.77 | $35.4K | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer | 2018-02-13 | 2018-02-13 | 5,130 | $18.00 | $92.3K | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | A Award deriv | 2018-02-01 | 2018-02-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2017-06-16 | 2017-06-19 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2017-06-16 | 2017-06-19 | 3,000 | — | $0 | 3,000 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2017-06-13 | 2017-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2017-06-01 | 2017-06-05 | 10,000 | — | $0 | 60,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-06-01 | 2017-06-05 | 5,130 | — | $0 | 14,930 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2017-01-03 | 2017-01-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2016-12-16 | 2016-12-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2016-06-17 | 2016-06-20 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2016-06-17 | 2016-06-20 | 3,000 | — | $0 | 3,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2016-06-02 | 2016-06-06 | 9,800 | — | $0 | 9,800 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2016-01-01 | 2016-01-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2015-06-24 | 2015-06-26 | 10,475 | — | $0 | 10,475 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2015-06-16 | 2015-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2015-05-29 | 2015-06-02 | 20,000 | — | $0 | 50,000 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2015-01-01 | 2015-01-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2014-12-10 | 2014-12-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2014-07-03 | 2014-07-08 | 12,090 | $2.29 | $27.7K | 1,071,125 | SEC↗ |
| CEMP CEMPRA, INC. | P Buy | 2014-05-23 | 2014-05-28 | 10,000 | $9.10 | $91.0K | 10,000 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2014-04-03 | 2014-04-04 | 9,459 | $2.93 | $27.7K | 1,083,215 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2014-03-26 | 2014-03-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DNDN DENDREON CORP | A Award deriv | 2014-02-10 | 2014-02-12 | 8,586 | $5.82 | $50.0K | 8,586 | SEC↗ |
| DNDN DENDREON CORP | A Award | 2014-02-10 | 2014-02-12 | 66,501 | — | $0 | 1,115,517 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2014-02-10 | 2014-02-12 | 22,843 | $2.81 | $64.2K | 1,092,674 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2014-01-08 | 2014-01-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2014-01-03 | 2014-01-07 | 35,796 | $3.08 | $110.3K | 1,049,016 | SEC↗ |
| DNDN DENDREON CORP | A Award | 2014-01-03 | 2014-01-07 | 395,189 | — | $0 | 1,084,812 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2013-12-31 | 2014-01-03 | 38,382 | $2.99 | $114.8K | 689,623 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2013-02-04 | 2013-02-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DNDN DENDREON CORP | A Award | 2013-01-03 | 2013-01-07 | 395,189 | — | $0 | 728,005 | SEC↗ |
| DNDN DENDREON CORP | F Tax w/h | 2012-12-31 | 2013-01-02 | 40,342 | $5.29 | $213.4K | 332,816 | SEC↗ |
| TZYM TRANZYME INC | A Award deriv | 2012-08-07 | 2012-08-09 | 21,044 | — | $0 | 21,044 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2012-03-20 | 2012-03-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DNDN DENDREON CORP | A Award deriv | 2012-01-31 | 2012-02-02 | 699,560 | $13.58 | $9.50M | 699,560 | SEC↗ |
| DNDN DENDREON CORP | A Award | 2012-01-31 | 2012-02-02 | 349,780 | — | $0 | 387,723 | SEC↗ |
| DNDN DENDREON CORP | A Award deriv | 2012-01-30 | 2012-09-24 | 667,608 | $14.17 | $9.46M | 667,608 | SEC↗ |
| DNDN DENDREON CORP | A Award | 2012-01-30 | 2012-09-24 | 335,215 | — | $0 | 373,158 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2012-01-03 | 2012-01-04 | 17,650 | $2.30 | $40.6K | 252,350 | SEC↗ |
| DNDN DENDREON CORP | A Award | 2012-01-03 | 2012-01-05 | 25,000 | — | $0 | 37,943 | SEC↗ |